CN1193016A - 噁唑衍生物的生产 - Google Patents
噁唑衍生物的生产 Download PDFInfo
- Publication number
- CN1193016A CN1193016A CN98106918.5A CN98106918A CN1193016A CN 1193016 A CN1193016 A CN 1193016A CN 98106918 A CN98106918 A CN 98106918A CN 1193016 A CN1193016 A CN 1193016A
- Authority
- CN
- China
- Prior art keywords
- amine
- methyl
- oxazoles
- alkyl group
- low alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 5
- 150000007978 oxazole derivatives Chemical class 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 32
- 150000001412 amines Chemical class 0.000 claims abstract description 21
- 238000006297 dehydration reaction Methods 0.000 claims abstract description 18
- -1 nitrogen-containing heteroaromatic compound Chemical class 0.000 claims abstract description 12
- VXEGSRKPIUDPQT-UHFFFAOYSA-N 4-[4-(4-methoxyphenyl)piperazin-1-yl]aniline Chemical compound C1=CC(OC)=CC=C1N1CCN(C=2C=CC(N)=CC=2)CC1 VXEGSRKPIUDPQT-UHFFFAOYSA-N 0.000 claims abstract description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims abstract description 10
- 230000018044 dehydration Effects 0.000 claims abstract description 10
- 239000005049 silicon tetrachloride Substances 0.000 claims abstract description 10
- 125000005270 trialkylamine group Chemical group 0.000 claims abstract description 6
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000003960 organic solvent Substances 0.000 claims abstract description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims abstract description 5
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims abstract description 4
- 125000001931 aliphatic group Chemical group 0.000 claims abstract description 4
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims abstract description 3
- 150000004292 cyclic ethers Chemical class 0.000 claims abstract description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 29
- 125000000217 alkyl group Chemical group 0.000 claims description 23
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 18
- VMJNTFXCTXAXTC-UHFFFAOYSA-N 2,2-difluoro-1,3-benzodioxole-5-carbonitrile Chemical group C1=C(C#N)C=C2OC(F)(F)OC2=C1 VMJNTFXCTXAXTC-UHFFFAOYSA-N 0.000 claims description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 150000002196 fatty nitriles Chemical class 0.000 claims description 2
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 2
- JZSLPQXOLZCAME-UHFFFAOYSA-N 4-methyl-1,3-oxazole-5-carbonitrile Chemical compound CC=1N=COC=1C#N JZSLPQXOLZCAME-UHFFFAOYSA-N 0.000 abstract 1
- HBKBZJZRIWAICY-UHFFFAOYSA-N 4-methyl-1,3-oxazole-5-carboxamide Chemical compound CC=1N=COC=1C(N)=O HBKBZJZRIWAICY-UHFFFAOYSA-N 0.000 abstract 1
- 150000003222 pyridines Chemical class 0.000 abstract 1
- 235000008160 pyridoxine Nutrition 0.000 abstract 1
- 239000011677 pyridoxine Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 150000003510 tertiary aliphatic amines Chemical class 0.000 abstract 1
- 229940011671 vitamin b6 Drugs 0.000 abstract 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 16
- 239000002904 solvent Substances 0.000 description 16
- 229910003902 SiCl 4 Inorganic materials 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 14
- 239000003513 alkali Substances 0.000 description 11
- 230000035484 reaction time Effects 0.000 description 11
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 10
- GNTDGMZSJNCJKK-UHFFFAOYSA-N divanadium pentaoxide Chemical compound O=[V](=O)O[V](=O)=O GNTDGMZSJNCJKK-UHFFFAOYSA-N 0.000 description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 8
- 208000005156 Dehydration Diseases 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000000197 pyrolysis Methods 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 229960001866 silicon dioxide Drugs 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 150000003016 phosphoric acids Chemical class 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- VQEDENJDYAWVOH-UHFFFAOYSA-N 2-methoxy-2-methylpropane;toluene Chemical compound COC(C)(C)C.CC1=CC=CC=C1 VQEDENJDYAWVOH-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- 241000588731 Hafnia Species 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007701 flash-distillation Methods 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- CJNBYAVZURUTKZ-UHFFFAOYSA-N hafnium(IV) oxide Inorganic materials O=[Hf]=O CJNBYAVZURUTKZ-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMHSKYSHOIGDPE-UHFFFAOYSA-N pyridine;quinoline Chemical compound C1=CC=NC=C1.N1=CC=CC2=CC=CC=C21 UMHSKYSHOIGDPE-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- 238000006277 sulfonation reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
溶剂 | 溶剂的量 | 反应时间(小时) | OXN产率 |
四氢呋喃甲苯叔丁基甲基醚乙腈N-甲基吡咯烷酮 | 80ml60ml80ml60ml80ml | 55542 | 85%31%46%95%96% |
碱 | 反应时间(小时) | XON的产率 |
三乙胺三(正丁基)胺吡啶喹啉 | 43.555.5 | 95%94%90%94% |
摩尔比SiCl4∶OXA | 反应时间(小时) | OXN的产率 |
3∶11.5∶11.3∶11.1∶1 | 51655 | 92.5%94.5%85.0%84.5% |
碱的量(当量) | SiCl4的量(当量) | 溶剂量(ml) | 反应时间(小时) | OXN的产率 |
2.12.82.82.82.8 | 0.70.70.70.735*0.735* | 8585170170285 | 6655.58 | 8887898995 |
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97102339.5 | 1997-02-13 | ||
EP97102339 | 1997-02-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1193016A true CN1193016A (zh) | 1998-09-16 |
CN1110487C CN1110487C (zh) | 2003-06-04 |
Family
ID=8226472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98106918.5A Expired - Fee Related CN1110487C (zh) | 1997-02-13 | 1998-02-12 | 噁唑衍生物的生产方法 |
Country Status (10)
Country | Link |
---|---|
US (1) | US5910594A (zh) |
EP (1) | EP0859001B1 (zh) |
JP (1) | JPH10218869A (zh) |
KR (1) | KR19980071278A (zh) |
CN (1) | CN1110487C (zh) |
BR (1) | BR9800601A (zh) |
CA (1) | CA2228866A1 (zh) |
DE (1) | DE59802280D1 (zh) |
DK (1) | DK0859001T3 (zh) |
ES (1) | ES2167813T3 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104203930A (zh) * | 2012-04-25 | 2014-12-10 | 帝斯曼知识产权资产管理有限公司 | 合成4-甲基噁唑-5-甲酰胺的方法 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2721015B1 (en) | 2011-06-20 | 2017-03-01 | DSM IP Assets B.V. | Process for 4-methyloxazole-5-carboxamide |
CN103435568B (zh) * | 2013-08-30 | 2015-05-13 | 大丰海嘉诺药业有限公司 | 一种4-甲基-5-乙氧基噁唑酸乙酯的制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH449623A (de) * | 1963-05-22 | 1968-01-15 | Hoffmann La Roche | Verfahren zur Herstellung von 4-Alkyl-5-cyan-oxazolen |
US4051174A (en) * | 1973-08-21 | 1977-09-27 | Hoffmann-La Roche Inc. | Isomerization process |
CH605724A5 (zh) * | 1974-11-12 | 1978-10-13 | Hoffmann La Roche | |
US4026901A (en) * | 1975-04-30 | 1977-05-31 | Hoffmann-La Roche Inc. | Conversion of 4-lower alkyloxazole-5-carboxamide to 4-lower alkyl-5-cyanooxazoles |
US4093654A (en) * | 1977-03-31 | 1978-06-06 | Hoffmann-La Roche Inc. | Production of pyridoxine intermediates from diketene |
CA1122220A (en) * | 1978-11-02 | 1982-04-20 | Hans Hoffmann-Paquotte | Process for the manufacture of an oxazole |
EP0224706A1 (de) * | 1985-11-01 | 1987-06-10 | F. Hoffmann-La Roche Ag | Verfahren zur Herstellung eines Oxazols |
US5214162A (en) * | 1990-12-21 | 1993-05-25 | Hoffman-La Roche Inc. | Process for manufacturing 5-cyano-4-lower alkyloxazoles |
EP0612736B1 (de) * | 1993-02-25 | 1999-04-14 | F. Hoffmann-La Roche Ag | Verfahren zur Herstellung von Oxazolderivaten |
EP0770604A1 (de) * | 1995-10-25 | 1997-05-02 | F. Hoffmann-La Roche Ag | Verfahren zur Herstellung von Oxazolderivaten |
-
1998
- 1998-01-20 US US09/008,793 patent/US5910594A/en not_active Expired - Fee Related
- 1998-02-03 JP JP10021655A patent/JPH10218869A/ja not_active Ceased
- 1998-02-05 ES ES98101934T patent/ES2167813T3/es not_active Expired - Lifetime
- 1998-02-05 CA CA002228866A patent/CA2228866A1/en not_active Abandoned
- 1998-02-05 DK DK98101934T patent/DK0859001T3/da active
- 1998-02-05 DE DE59802280T patent/DE59802280D1/de not_active Expired - Fee Related
- 1998-02-05 EP EP98101934A patent/EP0859001B1/de not_active Expired - Lifetime
- 1998-02-12 CN CN98106918.5A patent/CN1110487C/zh not_active Expired - Fee Related
- 1998-02-12 KR KR1019980004130A patent/KR19980071278A/ko not_active Application Discontinuation
- 1998-02-12 BR BR9800601A patent/BR9800601A/pt not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104203930A (zh) * | 2012-04-25 | 2014-12-10 | 帝斯曼知识产权资产管理有限公司 | 合成4-甲基噁唑-5-甲酰胺的方法 |
CN110229115A (zh) * | 2012-04-25 | 2019-09-13 | 帝斯曼知识产权资产管理有限公司 | 合成4-甲基噁唑-5-甲酰胺的方法 |
Also Published As
Publication number | Publication date |
---|---|
JPH10218869A (ja) | 1998-08-18 |
DE59802280D1 (de) | 2002-01-17 |
ES2167813T3 (es) | 2002-05-16 |
DK0859001T3 (da) | 2002-03-25 |
EP0859001B1 (de) | 2001-12-05 |
US5910594A (en) | 1999-06-08 |
BR9800601A (pt) | 1999-07-20 |
EP0859001A1 (de) | 1998-08-19 |
KR19980071278A (ko) | 1998-10-26 |
CN1110487C (zh) | 2003-06-04 |
CA2228866A1 (en) | 1998-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220411391A1 (en) | Intermediate compounds used for preparing brivaracetam, preparation methods for intermediate compounds, and use | |
US5326887A (en) | Process for the preparation of 1,4-dioxane-2,5-diones | |
CN1110487C (zh) | 噁唑衍生物的生产方法 | |
EP0177454A2 (de) | Silane, Verfahren zu deren Herstellung und deren Verwendung | |
Sivik et al. | Crystal structure analysis of an osmium (VI) bisglycolate produced by reaction of a sterically hindered chiral nonracemic alkene with osmium tetroxide | |
DE68907840T2 (de) | Verfahren zur katalytischen Herstellung von N-substituierten Acrylamiden und Methacrylamiden. | |
Yalpani et al. | Hydrated oxocarbons, IV. Silylation of 1, 1‐dihydroxy compounds | |
CN111087352B (zh) | 一种3-三氟烷基喹喔啉酮化合物的制备方法 | |
CN112680497A (zh) | 生物酶拆分前列腺素类药物关键中间体(1S,5R)-Corey内酯的方法 | |
CN1104213A (zh) | 制备5-氰基-4-低级烷基噁唑的方法 | |
CN116462622B (zh) | 一种N-Boc-L-脯氨醛的制备方法 | |
CN1718582A (zh) | 氯胺磷的制备方法 | |
CN110256315A (zh) | 一种制备含硫醚甲酰硫脂缀合物的方法 | |
US6359174B1 (en) | Lewis acid-catalyzed claisen rearrangement in the preparation of chiral products | |
CN114605494B (zh) | 一种阿加曲班及其中间体的制备方法 | |
GB1561464A (en) | Oxidation of alkaryl compounds | |
Ali et al. | Reaction of lithium enolates with carbon disulfide: synthesis of O-(1-alkoxy-2, 2-dialkylvinyl) S-alkyl dithiocarbonates | |
DE10123909A1 (de) | Verfahren zur Herstellung von Ketonen aus Carbonsäureanhydriden | |
CN115057882A (zh) | 一类多取代烯基锡试剂及其立体选择性制备与应用 | |
KR0129789B1 (ko) | N-알로일-c-(n-메틸아닐리노)이미도일클로라이드유도체및그제조방법 | |
CN1126724C (zh) | 多取代环戊二烯衍生物的合成方法 | |
CN115650892A (zh) | 一种制备碳-酰氧基取代氮杂环丙烷类化合物的方法 | |
CN1152000C (zh) | 一种具有螺环结构的多取代环戊二烯衍生物的合成方法 | |
CN118271192A (zh) | (3-氨基-5-乙基金刚烷-1-基)乙酸甲酯及其化学上可接受的盐 | |
CN114773189A (zh) | 一种羧酸高效酯化的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: DSM IP ASSET CO., LTD. Free format text: FORMER OWNER: FUEL HA FUMAN-LALUOQI LTD. Effective date: 20040224 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20040224 Address after: Holland Heerlen Patentee after: D Sm IP Assets Limited Address before: Basel Patentee before: F. Hoffmann-La Roche AG |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20030604 Termination date: 20170212 |